Literature DB >> 6869212

Acute hemodynamic effects of combined therapy with digoxin and nifedipine in patients with chronic heart failure.

I Cantelli, P C Pavesi, C Parchi, F Naccarella, D Bracchetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6869212     DOI： 10.1016/0002-8703(83)90197-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  9 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 2.  Calcium antagonists in patients with heart failure. A review.

Authors:  H Reicher-Reiss; E Barasch
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 3.  The rationale for combined use of diuretics, digitalis, and vasodilators in congestive heart failure.

Authors:  T W Smith; M A Pfeffer
Journal:  Cardiovasc Drugs Ther       Date:  1989-03       Impact factor: 3.727

Review 4.  Combination of positive inotropic and vasodilating substances in congestive heart failure.

Authors:  I Cantelli; D Bracchetti
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

5.  PY 108-068, a dihydropyridine derivative, and verapamil interact differently with the ouabain effects on the heart and the peripheral circulation.

Authors:  R P Hof; A Hof
Journal:  Basic Res Cardiol       Date:  1985 Jan-Feb       Impact factor: 17.165

6.  Influence of atenolol and nifedipine on digoxin-induced inotropism in humans.

Authors:  P B Hansen; J Buch; O O Rasmussen; S Waldorff; E Steiness
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

Review 7.  The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.

Authors:  A L Soward; G L Vanhaleweyk; P W Serruys
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

Review 8.  Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations.

Authors:  W J Remme
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

Review 9.  The use of digitalis for the treatment of congestive heart failure: a tale of its decline and resurrection.

Authors:  F I Marcus
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.